Status:
COMPLETED
Individual Sensitivity for Interstitial Lung Diseases
Lead Sponsor:
Maastricht University Medical Center
Conditions:
Interstitial Lung Diseases
Eligibility:
All Genders
18+ years
Brief Summary
Interstitial lung diseases (ILD) is a collective noun for various chronic lung diseases, including sarcoidosis and idiopathic lung fibrosis (IPF). Sarcoidosis is a multi-systemic disease that includes...
Eligibility Criteria
Inclusion
- ILD diagnosis confirmed by lung biopsy, X ray or BALF analysis
Exclusion
- smoking
- pregnancy or lactation
- use of vitamins or nutritional supplements
Key Trial Info
Start Date :
August 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2009
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00741572
Start Date
August 1 2008
End Date
September 1 2009
Last Update
February 24 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht University
Maastricht, Netherlands